RiverBabe's Baby Biotechs

[tiedyed1]

Thanks for sharing your opinion and the link.
It is always good to get a second set of eyes not to mention the experience shared on this board. I really appreciate it!

[peanuts]

Hey Riverbabe,

DNDN has a chart that looks ready to rumble... or is that rubble. I'll stick with the former.

Happy trails!

[riverbabe]

Hey Riverbabe,

DNDN has a chart that looks ready to rumble... or is that rubble. I'll stick with the former.

Happy trails!

I still love DNDN and am in for the long haul. I especially liked this analysis of the convertible debt sale: http://www.minyanville.com/businessm...als&from=yahoo

and this: http://www.fool.com/investing/high-g...portunity.aspx

JP Morgan analyst Cory Kasimov, in a note to clients last Friday, called Dendreon's European strategy a "tasty pre-conference appetizer." He added that the drug has an 85% chance of winning approval for sale in Europe, and could reach $2.25 billion in sales there by its peak year of 2018 -- even more than its $2 billion peak annual sales potential in the U.S. In his view, that means the Provenge European prospects are worth about another $17 a share, and the stock could climb to $66 a share by December, Kasimov said.

Love those happy trails!

[billyjoe]

River,
Here's one not mentioned for a long time......AFFX. A person I won't name that has an outstanding track record of stock picking likes it and I just bought quite a bit and am willing to hold for 6 months or more. Their business is genetic analysis, DNA chips, and reagents.

-------------billy

[riverbabe]

River,
Here's one not mentioned for a long time......AFFX. A person I won't name that has an outstanding track record of stock picking likes it and I just bought quite a bit and am willing to hold for 6 months or more. Their business is genetic analysis, DNA chips, and reagents.

-------------billy

Affymetrix is a well established company I have liked for a long time. Its recent acquisition of Thermo Fisher is a definite positive catalyst. (Disclosure: my father-in-law worked for Fisher Scientific for years and years and years. I am also familiar with their products through my former research and hospital lab experience).

http://www.fool.com/investing/general/2011/01/12/affymetrix-shares-popped-what-you-need-to-know.aspx

The chart is beautiful with a good buy point of about 5.30. Congrats billy! And thank you for bringing it here!

[billyjoe]

Apparently the fat lady has sung for MNKD. FDA wants 2 more clinical trials for Afrezza. MNKD spokesman says that could take 2 years to complete. Shares fall over 44% in extended trading from 9.11 to 5.04. My newfound conservative investing has saved me.

--------------billy

[riverbabe]

Apparently the fat lady has sung for MNKD. FDA wants 2 more clinical trials for Afrezza. MNKD spokesman says that could take 2 years to complete. Shares fall over 44% in extended trading from 9.11 to 5.04. My newfound conservative investing has saved me.

--------------billy

ditto for me. Poorer Al Mann, who bot even more shares before this announcement, poorer Al. The latest video of his that I watched was not enthusiastic, for him the most enthusiastic of promoters. So I was not motivated to buy. Happy happy I didn't. Feel sorry for him. If it ever gets approved, it could be HUGE!!! But, his statement that the FDA spent TWO WEEKS looking at the facilities that did the comparative studies between the original device data and the new device data (instead of about two days) made me think there was going to be a problem. Sat on my hands, thank God.

[riverbabe]

Mnkd

This is a link to the SEC filing (8-K) by Mannkind about the Complete Response Letter from the FDA:

http://www.investors.mannkindcorp.com/phoenix.zhtml?c=147953&p=IROL-sec

The second link is to Adam Feuerstein's article today at TheStreet.com

http://www.thestreet.com/story/10979582/1/mannkind-founder-loses-cult-status.html

[riverbabe]

The FDA letter secrecy

Another example of what biotech investors are up against:

http://blogs.forbes.com/matthewherper/2011/01/20/mannkind-beconds-poster-child-for-dangers-of-fda-secrecy/?partner=yahootix

Best quote of the day:

matthewherper Matthew Herper
by adamfeuerstein
I think @aviksaroy's note has the best $MNKD headline. "A Giant Leap Backward For MannKind."

[billyjoe]

Affymetrix is a well established company I have liked for a long time. Its recent acquisition of Thermo Fisher is a definite positive catalyst. (Disclosure: my father-in-law worked for Fisher Scientific for years and years and years. I am also familiar with their products through my former research and hospital lab experience).

http://www.fool.com/investing/general/2011/01/12/affymetrix-shares-popped-what-you-need-to-know.aspx

The chart is beautiful with a good buy point of about 5.30. Congrats billy! And thank you for bringing it here!

River,
I'm all in now. Bought at 5.30 shortly before your post and again today at 5.08. Barchart has support at 4.97 and 4.84. Resistance 5.31 and 5.52. VV has a stop at 4.68.

----------billy

[billyjoe]

AFFX again

River,

I found this article interesting. http://finance.yahoo.com/news/Affyme....html?x=0&.v=1

Several years ago I was heavily into the Fern and Hosta business. Many new varieties are patented but patent owners had problems when other companies would propagate the patented varieties, sell great quantities of them without paying royalties, and claim they had discovered the varieties, often as a mutated seedling. A company, perhaps AFFX, came up with a method of putting a genetic marker in the plants. You could say it was like checking DNA of the plant to see if it had been kidnapped. I don't know how this has developed over the past ten years but I've heard reports of greenhouses being raided and 10's of thousands of plants being destroyed, just like the old bootlegging days.

-------------billy

[riverbabe]

Affx

So that's what the article was all about! Fascinating billy.

[edward]

River,
Any insight as to what's going on with Rexahn, RNN? I see it's on the rise again. Quite a big move today. Thanks!

[riverbabe]

River,
Any insight as to what's going on with Rexahn, RNN? I see it's on the rise again. Quite a big move today. Thanks!

The word is it's because of this article:

http://seekingalpha.com/article/247986-rexahn-pharma-is-considerably-undervalued-based-on-prospects-recent-developments?source=yahoo

I don't have any interest in it right now though.

[edward]

Thanks for the great info. Could be worth keeping an eye on. I'd love a repeat of last spring's run-up!